HIGHLIGHTS
- who: Lu Wang et al. from the Department of Clinical Laboratory, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Peking University Cancer Hospital and Institute, Beijing, China have published the article: Serum LAPTM4B as a Potential Diagnostic and Prognostic Biomarker for Breast Cancer, in the Journal: BioMed Research International of 30/Nov/2022
- what: This study is aimed at understanding the clinical significance of serum LAPTM4B in breast cancer (BC). The authors examine the serum levels of LAPTM4B in BC and control for diagnostic accuracy.
- how: Sera from a subset of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.